Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Cantanhede
State: Coimbra
Zip:
Country: Portugal
Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions. Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product, Exo-Wound, for the treatment of chronic wounds. The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2015 | Seed Round | 2 | $870.5k |
Caixa Capital ChangePartners Caixa Capital ChangePartners |
12/2016 | Grant | 1 | $53.3k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|